CliffBio
small molecule

FEMSTAT 3

BUTOCONAZOLE NITRATE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameFEMSTAT 3
Active ingredientBUTOCONAZOLE NITRATE
Strength2%
Dosage formCREAM
RouteVAGINAL
ModalitySmall molecule
FDA approvalDecember 1995
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.